Using Cellvizio to assess surgical margins in Crohn's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Cellvizio, a technology that allows for real-time imaging during surgery, to assess the microscopic inflammation at resection margins in patients undergoing ileocaecal resection for Crohn's disease. The goal is to determine if this imaging can help surgeons make more informed decisions about the extent of resection needed to minimize the risk of postoperative recurrence. By identifying inflammation that may not be visible to the naked eye, the study aims to improve surgical outcomes for patients with Crohn's disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who need a ileocaecal resection for a Crohn disease whatever is the phenotype of the Crohn's disease

Exclusion Criteria:

* Patients\<18 years old,
* pregnancy or breastfeeding,
* patients who have an ileocolic resection for a surgical recurrence of the Crohn's disease.
* Patients operated in emergency for a peritonitis,
* patients who have a contra-indication for fluorescein injection or severe allergia to any drug

Where it's running

• CHU Amiens Picardie
  Amiens, France Recruiting

Study contacts

• Study coordinator: Charles Sabbagh, Pr
• Email: sabbagh.charles@chu-amiens.fr
• Phone: 03 22 08 88 96

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two surgical methods for Crohn's disease treatment

  This study is testing which of two surgical methods works better for treating Crohn's disease in patients needing bowel surgery to see which one leads to fewer problems after the operation.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05658081

• Microencapsulated Propionate vs Butyrate for Crohn's Disease in Remission

  This study tests whether microencapsulated sodium propionate can favorably alter the gut microbiota and inflammation in adults with Crohn’s disease, compared with sodium butyrate.

  Recruiting University of Padova · Padova · NCT07883044

• Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

  This study tests whether risankizumab can help people with Crohn’s disease who have draining perianal fistulas not responding to other treatments.

  Recruiting Phase 4 Hyogo Medical University · Nishinomiya and 3 other locations · NCT07872449

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Laser-based sizing of GI lesions during endoscopies

  This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07770425

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.